HONG KONG, Sept 21, 2026 - (ACN Newswire) - Everest Medicines announced findings from a longitudinal study describing how paroxysmal supraventricular tachycardi
| Quartal / Datum | EPS () | Schätzung () | Abweichung |
|---|
| Quartal / Datum | Umsatz (Mio ) | Schätzung (Mio ) | Abweichung |
|---|